SCALE Payer and Regulatory Research Policy Updates: April 18, 2024
Senate Holds Hearing on Physician Payment Reform On April 11, the Senate Finance Committee held a hearing on Medicare Clinician Payment Improvements, recognizing that Medicare
Senate Holds Hearing on Physician Payment Reform On April 11, the Senate Finance Committee held a hearing on Medicare Clinician Payment Improvements, recognizing that Medicare
Congress Enacts Funding Bill that Includes Physician Payment Changes On March 9 Consolidated Appropriations Act of 2024 was signed by the President and became law,
In recent years, CMS has been investing resources and rolling out programs to introduce value-based care models focusing on a variety of medical specialties. On
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research February 2024CMS Announces MA Rate Notice and Implementation of Medicare Part D Changes • On January
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research January 2024 Health Care Legislation Faces Unusual Congressional Timeline • In 2023, Congressional leaders used a
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research CMS Strengthens Primary Care in 2024 Medicare Physician Fee Schedule while Specialists see Relative Cuts On
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research November 2023 CMS Finalizes 2024 Physician Payment Rule On November 2, CMS issued the Medicare Physician
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research October 2023 Federal Court Limits Copay Accumulators On October 3, a federal judge ruled against a
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research September 2023 Congress and FDA Seek Drug Shortage Solutions Amid ongoing drug shortages for generic medications used
Margaret Braxton Managing Director, Payer Strategy and Regulatory Research August 2023 FDA Approves First Oral Postpartum Depression Drug On August 4, the FDA granted approval